Background Image
Previous Page  93 / 106 Next Page
Information
Show Menu
Previous Page 93 / 106 Next Page
Page Background

93

[81] Stuurgroep Weesgeneesmiddelen, “Expertise voor zeldzame aandoeningen in Nederland. Bevindingen

en conclusies naar aanleiding van consultatie door de Stuurgroep Weesgeneesmiddelen (2010-2011).”

Dec-2011.

[82] VSOP, “Informatie voor de huisarts over Neurofibromatose type 2.” VSOP, Soest, 2014.

[83] Stuurgroep Zwangerschap en geboorte, “Een goed begin. Veilige zorg rond zwnagerschap en geboorte,”

Dec. 2009.

[84]D. G. Evans, M. E. Baser, B. O’Reilly, J. Rowe, M. Gleeson, S. Saeed, A. King, S. M. Huson, R. Kerr, N.

Thomas, R. Irving, R. MacFarlane, R. Ferner, R. McLeod, D. Moffat, and R. Ramsden, “Management of the

patient and family with neurofibromatosis 2: a consensus conference statement,”

Br J Neurosurg

, vol.

19, no. 1, pp. 5–12, 2005.

[85] Intergraal kankercentrum Nederland, “Detecteren behoefte psychosociale zorg.” 2010.

[86] L. Beni-Adani, S. Pomeranz, I. Flores, Y. Shoshan, Y. Ginosar, and I. Ben-Shachar, “Huge acoustic

neurinomas presenting in the late stage of pregnancy. Treatment options and review of literature,”

Acta

Obstet. Gynecol. Scand.

, vol. 80, no. 2, pp. 179–184, Feb. 2001.

[87] J. B. Sharma, P. Pundir, and A. Sharma, “Acoustic neuroma in pregnancy: emergency cesarean section

and definitive neurosurgery,”

Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet.

, vol. 80, no.

3, pp. 321–323, Mar. 2003.

[88] P. M. Abou-Sleiman, A. Apessos, J. C. Harper, P. Serhal, R. M. L. Winston, and J. D. A. Delhanty, “First

application of preimplantation genetic diagnosis to neurofibromatosis type 2 (NF2),”

Prenat. Diagn.

, vol.

22, no. 6, pp. 519–524, Jun. 2002.

[89] R. K. Gaughan and S. G. Harner, “Acoustic neuroma and pregnancy,”

Am. J. Otol.

, vol. 14, no. 1, pp. 88–

91, Jan. 1993.

[90] “Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development

Conference,”

Arch. Neurol.

, vol. 45, no. 5, pp. 575–578, May 1988.

[91] S. R. Plotkin, J. O. Blakeley, D. G. Evans, C. O. Hanemann, T. J. M. Hulsebos, K. Hunter-Schaedle, G. V.

Kalpana, B. Korf, L. Messiaen, L. Papi, N. Ratner, L. S. Sherman, M. J. Smith, A. O. Stemmer-Rachamimov,

J. Vitte, and M. Giovannini, “Update from the 2011 International Schwannomatosis Workshop: From

genetics to diagnostic criteria,”

Am. J. Med. Genet. A.

, vol. 161A, no. 3, pp. 405–416, Mar. 2013.

[92]D. G. R. Evans, C. Watson, A. King, A. J. Wallace, and M. E. Baser, “Multiple meningiomas: differential

involvement of the NF2 gene in children and adults,”

J. Med. Genet.

, vol. 42, no. 1, pp. 45–48, Jan. 2005.

[93]D. G. Evans, “Neurofibromatosis 2,” in

GeneReviews(®)

, R. A. Pagon, M. P. Adam, H. H. Ardinger, T. D.

Bird, C. R. Dolan, C.-T. Fong, R. J. Smith, and K. Stephens, Eds. Seattle (WA): University of Washington,

Seattle, 1993.

[94] I. Ahronowitz, W. Xin, R. Kiely, K. Sims, M. MacCollin, and F. P. Nunes, “Mutational spectrum of the NF2

gene: a meta-analysis of 12 years of research and diagnostic laboratory findings,”

Hum. Mutat.

, vol. 28,

no. 1, pp. 1–12, Jan. 2007.

[95] J. Kanzaki, M. Tos, M. Sanna, D. A. Moffat, E. M. Monsell, and K. I. Berliner, “New and modified reporting

systems from the consensus meeting on systems for reporting results in vestibular schwannoma,”

Otol.

Neurotol. Off. Publ. Am. Otol. Soc. Am. Neurotol. Soc. Eur. Acad. Otol. Neurotol.

, vol. 24, no. 4, pp. 642–

648; discussion 648–649, Jul. 2003.

[96] S. J. Han, M. C. Oh, M. E. Sughrue, M. J. Rutkowski, D. Aranda, I. J. Barani, and A. T. Parsa, “The effect of

the 2003 Consensus Reporting Standards on publications describing patients with vestibular

schwannoma treated with stereotactic radiosurgery,”

J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas.

,

vol. 19, no. 8, pp. 1144–1147, Aug. 2012.

[97]W. T. Koos, J. D. Day, C. Matula, and D. I. Levy, “Neurotopographic considerations in the microsurgical

treatment of small acoustic neurinomas,”

J. Neurosurg.

, vol. 88, no. 3, pp. 506–512, Mar. 1998.

[98] J. O. Blakeley, D. G. Evans, J. Adler, D. Brackmann, R. Chen, R. E. Ferner, C. O. Hanemann, G. Harris, S. M.

Huson, A. Jacob, M. Kalamarides, M. A. Karajannis, B. R. Korf, V. F. Mautner, A. I. McClatchey, H. Miao, S.

R. Plotkin, W. Slattery, A. O. Stemmer-Rachamimov, D. B. Welling, P. Y. Wen, B. Widemann, K. Hunter-